Fundalysisby DARKHORSESTOCKS

Scheme

Nippon India Nifty Pharma ETF

Holds 20 companies worth ₹1,736 Cr in Sept 2026.

  • Fund house

    NipponThe fund house that runs this scheme.

  • AUM

    ₹1,736 CrNippon India Nifty Pharma ETF's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 1.4% on Aug 2026, ₹1,761 Cr.

  • Largest holding

    Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 19.5% of this scheme's NAV.

  • Fund manager

    Jitendra TolaniRuns it since 1 Feb 2025, as the fund house dates it.

AUM(Sept 2021 – Sept 2026)

AUM at month end each month, and its change on the month before
12 months₹ CrChange
Sept 20261,736−1.4%
Aug 20261,761+4.1%
Jul 20261,691+4.3%
Jun 20261,622+3.3%
May 20261,570+15.8%
Apr 20261,356+8.7%
Mar 20261,248+17.9%
Feb 20261,059+5.1%
Jan 20261,007−1.9%
Dec 20251,027−0.7%
Nov 20251,034+1.1%
Oct 20251,023+3.3%
AUM at month end, Sept 2026
₹1,736 Cr
+69.8% since Oct 2025
Fig. 1.AUM at each month's end, ₹ crore; under All, the quarterly average since 2010. Source: AMFI.

Returns(9 Oct 2026)

Growth · Direct and Regular plans

To 9 Oct 2026; past a year, a yearly rate. Benchmark: Nifty Pharma TRI. * From NAVs. Source: AMFI. Click a column's header to sort by it.
1 month *
−2.75%–––−4.16%
3 months *
+1.31%–––−5.09%
6 months *
+17.55%–––−1.17%
1 year
–+18.78%+19.06%––
3 years
–+20.26%+20.56%––
5 years
–+12.88%+13.14%––
Since launch
–+12.43%+12.70%––
Fig. 3.To 9 Oct 2026; past a year, a yearly rate. Benchmark: Nifty Pharma TRI. * From NAVs. Source: AMFI.